Drug profile · INN
irinotecan
IRINOTECAN ACCORD
irinotecan (IRINOTECAN ACCORD) is a dna topoisomerase i inhibitor. Associated with BAXTER HEALTHCARE PTY LTD.
TGA: approved NMPA: clinical trials
Patents linked 1
Pipeline programs 79
News articles 0
Drug details — irinotecan
- Class
- —
- Route
- —
- Patents
- 1
- Programs
- 79
- Data quality
- 0.81
Quick answer
irinotecan (IRINOTECAN ACCORD) is a dna topoisomerase i inhibitor. Associated with BAXTER HEALTHCARE PTY LTD.
Key facts
INN irinotecan
Brand IRINOTECAN ACCORD
Mechanism DNA topoisomerase I inhibitor
Originator BAXTER HEALTHCARE PTY LTD
Mechanism of action
DNA topoisomerase I inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related patents
Frequently asked questions
What is irinotecan?
irinotecan (IRINOTECAN ACCORD) is a dna topoisomerase i inhibitor. Associated with BAXTER HEALTHCARE PTY LTD.
What is the brand name for irinotecan?
IRINOTECAN ACCORD is a marketed brand name for irinotecan. Check FDA Drugs@FDA for the current US label holder and prescribing information.